Sale!

MAN2B1 Gene Alpha-Mannosidosis Genetic Test

Original price was: $700.Current price is: $500.

-29%

The MAN2B1 Gene Alpha-Mannosidosis NGS Genetic DNA Test is a cutting-edge genetic screening that identifies mutations in the MAN2B1 gene responsible for alpha-mannosidosis, a rare inherited metabolic disorder. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to detect pathogenic variants that disrupt lysosomal enzyme function, leading to the accumulation of complex sugars in cells. Early detection through this $500 USD test enables timely intervention and management strategies for affected individuals. The test is particularly valuable for individuals exhibiting developmental delays, skeletal abnormalities, hearing loss, or immune system deficiencies. By providing precise genetic information, this screening helps guide appropriate medical care, genetic counseling, and family planning decisions for those at risk of this progressive lysosomal storage disease.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

MAN2B1 Gene Alpha-Mannosidosis NGS Genetic DNA Test

Comprehensive Genetic Screening for Rare Metabolic Disorders

The MAN2B1 Gene Alpha-Mannosidosis NGS Genetic DNA Test represents a breakthrough in precision medicine for diagnosing rare inherited metabolic conditions. This advanced genetic screening utilizes cutting-edge Next-Generation Sequencing technology to identify mutations in the MAN2B1 gene, which encodes the enzyme alpha-mannosidase. When this enzyme is deficient, complex sugar molecules called oligosaccharides accumulate in lysosomes, leading to progressive cellular damage and the characteristic symptoms of alpha-mannosidosis.

What This Test Measures and Detects

Our comprehensive NGS genetic analysis specifically targets the MAN2B1 gene located on chromosome 19, examining all coding regions and splice sites for pathogenic variants. The test detects:

  • Missense, nonsense, and frameshift mutations in the MAN2B1 gene
  • Small deletions and insertions affecting enzyme function
  • Splice site variants that disrupt proper gene expression
  • Compound heterozygous mutations in affected individuals
  • Carrier status identification in asymptomatic family members

Who Should Consider This Genetic Screening

This specialized genetic test is recommended for individuals presenting with clinical features suggestive of alpha-mannosidosis, including:

  • Infants and children with developmental delays and intellectual disability
  • Patients exhibiting coarse facial features and skeletal abnormalities
  • Individuals with recurrent infections and immune system deficiencies
  • Those experiencing progressive hearing loss and speech difficulties
  • Patients with hepatosplenomegaly and connective tissue disorders
  • Family members of diagnosed individuals seeking carrier status information
  • Couples with family history of lysosomal storage disorders planning pregnancy

Significant Benefits of Early Genetic Detection

Undergoing the MAN2B1 Gene Alpha-Mannosidosis NGS Genetic DNA Test provides numerous advantages for patients and families:

  • Accurate Diagnosis: Provides definitive genetic confirmation of alpha-mannosidosis, eliminating diagnostic uncertainty
  • Early Intervention: Enables prompt initiation of appropriate management strategies and supportive care
  • Family Planning Guidance: Informs reproductive decisions through precise carrier risk assessment
  • Personalized Treatment: Guides targeted therapeutic approaches based on specific genetic mutations
  • Prognostic Information: Helps predict disease progression and potential complications
  • Clinical Trial Eligibility: Opens access to emerging treatments and research opportunities

Understanding Your Genetic Test Results

Our comprehensive genetic counseling support helps you interpret your MAN2B1 gene analysis results:

  • Positive Result: Identification of pathogenic mutations confirms alpha-mannosidosis diagnosis, enabling immediate medical management and family screening
  • Negative Result: No disease-causing variants detected significantly reduces likelihood of alpha-mannosidosis, though clinical correlation remains essential
  • Variant of Uncertain Significance: Genetic changes with unclear clinical impact require ongoing monitoring and family studies
  • Carrier Status: Identification of single mutation carriers informs reproductive risk assessment and family planning decisions

Test Pricing and Availability

Test Description Regular Price Discount Price
MAN2B1 Gene Alpha-Mannosidosis NGS Genetic DNA Test $700 USD $500 USD

Nationwide Testing Accessibility

We maintain comprehensive testing facilities across the United States, with specialized genetic centers in New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and all major metropolitan areas. Our network ensures convenient access to advanced genetic testing regardless of your location.

Take Action for Your Genetic Health

Don’t let uncertainty about potential genetic disorders impact your health decisions. Our MAN2B1 Gene Alpha-Mannosidosis NGS Genetic DNA Test provides the clarity needed for informed medical management and family planning. With results available in 3-4 weeks and multiple sample collection options including blood, extracted DNA, or FTA card blood spots, accessing this crucial genetic information has never been more convenient.

Schedule your genetic consultation today by calling our dedicated genetics hotline at +1(267) 388-9828 or book your appointment online through our secure patient portal. Take the first step toward genetic clarity and personalized healthcare management.